Metraipolis › archive › dc_7e79bd1417dd

Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives — Europe PMC PMID:41304743

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304743
DOI
10.3390/pharmaceutics17111405
License (as archived)
solo-consultazione
Archived
2026-11-08T22:44:27.108Z
SHA-256 of the archived text
5696c0fa789fbb80af6407b658d6202eb37ba98f7df438f31cdd7e640072dee8
Stable URL of this page
https://metraipolis.com/documento/dc_7e79bd1417dd

How to cite

Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives — Europe PMC PMID:41304743 — Europe PMC (en), https://europepmc.org/article/MED/41304743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e79bd1417dd (Metraipolis archive dc_7e79bd1417dd, sha256 5696c0fa789fbb80af6407b658d6202eb37ba98f7df438f31cdd7e640072dee8)
BibTeX
@misc{dc7e79bd1417dd,
  title = {Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives — Europe PMC PMID:41304743},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304743},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e79bd1417dd; sha256 5696c0fa789fbb80af6407b658d6202eb37ba98f7df438f31cdd7e640072dee8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304743. Agents can read the archived copy with the MCP tool read_document.